Headline: Are you concerned about your cannabis usage?

UVA Tracking #
Principal Investigator
Nassima A Tiouririne
Tracie Kostelac
Contact Email
Contact Phone
Official Trial Title
A Phase 2, Multicenter, Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled, Clinical Trial of Titrating Doses of Nabilone with Gabapentin for the Mitigation of Cannabis Withdrawal Symptoms
Study Description

The UVA Center for Leading Edge Addiction Research or CLEAR clinic is seeking men and women ages 18 to 55 who want to reduce their cannabis usage to participate in a research study to test the effectiveness of an investigational medication. The purpose of the study is to see if the investigational drug is effective in reducing withdrawal symptoms in individuals who want to eliminate their regular cannabis usage.

The trial involves 9 in-person visits and 3 telemedicine interviews over a 10 week period. All study-related exams, tests and investigational medication are given at no cost and compensation for visit completion will be provided.

Please contact us for more information and confidential screening at 434-243-0563 or uvaclear@virginia.edu.


No Compensation